Raymond James Reaffirms Outperform Rating for Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive (NYSE:CL)‘s stock had its “outperform” rating reissued by equities researchers at Raymond James in a research report issued on Monday,Benzinga reports. They currently have a $105.00 price objective on the stock, down from their previous price objective of $110.00. Raymond James’ price objective suggests a potential upside of 21.59% from the company’s previous close.

Other equities analysts have also issued research reports about the company. Barclays lowered their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Wells Fargo & Company decreased their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. UBS Group lowered their price objective on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. Finally, Piper Sandler cut their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $101.79.

Colgate-Palmolive Trading Down 0.4 %

CL stock opened at $86.36 on Monday. Colgate-Palmolive has a one year low of $82.68 and a one year high of $109.30. The stock has a market cap of $70.55 billion, a price-to-earnings ratio of 24.52, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44. The company has a fifty day moving average price of $91.35 and a two-hundred day moving average price of $97.15. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the business posted $0.87 earnings per share. Equities analysts anticipate that Colgate-Palmolive will post 3.74 EPS for the current year.

Insider Buying and Selling

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.37% of the stock is currently owned by corporate insiders.

Institutional Trading of Colgate-Palmolive

Institutional investors and hedge funds have recently bought and sold shares of the stock. Ieq Capital LLC grew its position in shares of Colgate-Palmolive by 25.2% in the 4th quarter. Ieq Capital LLC now owns 58,008 shares of the company’s stock valued at $5,274,000 after buying an additional 11,666 shares during the last quarter. Private Advisor Group LLC lifted its stake in shares of Colgate-Palmolive by 12.0% in the fourth quarter. Private Advisor Group LLC now owns 77,231 shares of the company’s stock worth $7,021,000 after acquiring an additional 8,279 shares during the period. Atlas Legacy Advisors LLC acquired a new position in shares of Colgate-Palmolive in the fourth quarter worth approximately $311,000. Bank of Jackson Hole Trust bought a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $89,000. Finally, Mcdonald Partners LLC raised its holdings in Colgate-Palmolive by 1.8% during the 4th quarter. Mcdonald Partners LLC now owns 9,996 shares of the company’s stock worth $909,000 after purchasing an additional 172 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.